Vioxx Users to Challenge Safety Claims
17th Nov 2005, 00:00 GMT
Whether the once-popular painkiller Vioxx can be lethal if taken for just a few weeks will be the crux of the 1st federal trial concerning the drug's safety, plaintiff's lawyers said.
Vioxx Users to Challenge Safety Claims related news:
- Vioxx users to challenge safety claims — SacBee -- Business News
- Federal Vioxx plaintiffs to challenge Merck claims on Vioxx safety — New Jersey News
- Uncertainty surrounds latest Vioxx cases — FT.com / Companies
- Bottles of the prescription arthritis and pain medication Vioxx. ... — Top Stories Photos - Reuters on Yahoo! News Photos
- Limited use of Vioxx at issue in next trial — RedOrbit News - General
- Councils urged to challenge bogus claims — Guardian Unlimited UK Latest
- Limited Vioxx use at issue in next trial (Reuters) — Yahoo! News: Business
- Limited Vioxx use at issue in next trial — Reuters: Business
- Next Trial to Focus on Limited Vioxx Use — FOXNews.com - Business
- Lawyers argue about the true meaning of Vioxx research — New Jersey News
Latest news from Operations-Related News from StratCenter.com:
- Senior Housing Properties Trust Announces Proposed Public Offering of 5 mln Common Shares
- King Not Loving Its Shareholders
- Sepracor says asthma drug data is favorable
- Sepracor Presents Data on Asthma Drug
- Dr Reddy's Registers to List Shares
- PolyMedica Corp CEO to Ring the NASDAQ Stock Market Opening Bell
- Biovail to Present at the CSFB 2006 Healthcare Conference
- Genelabs reports lower Q3 loss
- Solexa posts narrowed Q3 loss
- Abbott's Humira Positive in 2 Studies